(Total Views: 707)
Posted On: 07/06/2020 5:05:15 PM
Post# of 154952
In the context of manufacturing NP mentioned Lonza twice before switichung back to Samsung Bio.
IMHO CytoDyn MM are talking behind the scences with Lonza about an alternative supply chain.
The current one seems to be:
1.) SB produces in South Korea and deep frozen block of LL are flown into the US where AGC fills it into vials.
2.) Lonza has a production site in Kalama, WA less than 1 hour away from Vancouver. They could pot. produce LL and fill it into syringes straight away for HIV. Or act as a local supply alternative pending FDA approval to switch production under unmet medical need authorisation.
Lots of speculation I know, but makes sense to me.
Regards from Germany
baggo-mh
IMHO CytoDyn MM are talking behind the scences with Lonza about an alternative supply chain.
The current one seems to be:
1.) SB produces in South Korea and deep frozen block of LL are flown into the US where AGC fills it into vials.
2.) Lonza has a production site in Kalama, WA less than 1 hour away from Vancouver. They could pot. produce LL and fill it into syringes straight away for HIV. Or act as a local supply alternative pending FDA approval to switch production under unmet medical need authorisation.
Lots of speculation I know, but makes sense to me.
Regards from Germany
baggo-mh
(3)
(0)
